Overview

Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Status:
Completed
Trial end date:
2019-12-26
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, single-dose study to evaluate the safety, pharmacokinetics in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Nuance Pharma (shanghai) Co., Ltd
Treatments:
Bupivacaine